Post-Market Study of the Signia Circular Stapler With Tri-Staple Technology in Left-sided Colon, Sigmoid, and Rectal Resections

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorMedtronic - MITG

About this trial

The purpose of this study is to evaluate the safety and performance of the Signia™ power handle, Signia™ circular adapter, and Signia™ Tri-Staple™ 2.0 circular reloads (hereafter referred to as Signia™ circular stapler) in patients undergoing left sided colon, sigmoid, or rectal resections in a post market setting.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Subject is competent and willing to provide documented informed consent to participate in this clinical study

Subject is intended to undergo an elective left sided colon/colorectal procedure where a creation of an anastomosis will be completed with the Signia™ circular stapler

Subject is ≥ 18 years of age at time of consent

Disqualifiers

Subject is unable or unwilling to comply with the study requirements or follow-up schedule

Subject with ASA classification ≥ IV

Subject is pregnant (as determined by standard site practices)

The procedure is an emergency procedure

Trial design

Design model

Single group

Treatments tested in this trial

  • Signia™ circular stapler with Tri-Staple™ Technology (Signia™ Circular Stapling system)

    Device

    Signia™ Circular Stapling system used for the creation of an anastomosis

Treatment groups

137 Participants
are divided into 1 treatment group
Group A: Left sided colon/colorectal procedure with creation of an anastomosisExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Incidence of anastomotic leak

Incidence of anastomotic leak following the use of the Signia™ circular stapler used in subjects undergoing left sided colon, sigmoid, or rectal resections. Diagnosis will be confirmed postoperatively by computed tomography (CT) imaging (with or without a contrast agent), or postoperatively via direct verification during re-operation. Anastomotic leakage confirmed to have occurred at a staple line other than the colon/colorectal anastomosis created with the Signia™ circular stapler will not impact the primary endpoint analysis.

Time frame
within 30 days, +/- 14 days

Secondary outcomes

1

Incidence of anastomotic leaks

Incidence of anastomotic leak following the use of the Signia™ circular stapler used in subjects undergoing left sided colon, sigmoid, or rectal resections. Diagnosis will be confirmed postoperatively by computed tomography (CT) imaging (with or without a contrast agent), or postoperatively via direct verification during re-operation. Anastomotic leakage confirmed to have occurred at a staple line other than the colon/colorectal anastomosis created with the Signia™ circular stapler will not impact the primary endpoint analysis.

Time frame
within 90 days, +/- 14 days
2

Clinical significance of anastomotic leaks

Anastomotic leaks graded according to International Study Group of Rectal Cancer (ISGRC): Grade A: Anastomotic leakage results in no change in patients' management. Grade B: Leakage requires active therapeutic intervention but is manageable without re-laparotomy/operative intervention\*. Grade C: Anastomotic leakage requires re-laparotomy/operative intervention\*. \*Operative intervention was added to the ISGRC definition for the purpose of this study.

Time frame
within 90 days, +/- 14 days
3

Incidence of a Signia™ circular stapler and accessory components device deficiency (DD)

Inadequacy of a medical device with respect to its identity, quality, durability, reliability, usability, safety, or performance.

Time frame
Day 0 (day of surgery)
4

Incidence of anastomotic bleeding

bleeding at the anastomotic site that requires endoscopic or surgical intervention

Time frame
within 30 and 90 days, +/- 14 days

Other outcomes

1

Surgeon satisfaction

Surgeon satisfaction via a questionnaire

Time frame
Day 0 (day of surgery)
2

Incidence of serious device-related adverse events

serious device-related adverse events related to Signia™ circular stapler and accessory components. A serious adverse event is defined as an "Adverse event that led to any of the following: 1. Death, 2. Serious deterioration in the health of the subject, users or other persons as defined by one or more of the following: 1. a life-threatening illness or injury, or 2. a permanent impairment of a body structure or a body function including chronic diseases, or 3. in-patient or prolonged hospitalization, or 4. medical or surgical intervention to prevent life-threatening illness or injury, or permanent impairment to a body structure or a body function, or 3. foetal distress, foetal death, a congenital abnormality, or birth defect including physical or mental impairment.

Time frame
within 90 days, +/- 14 days
3

Clavien-Dindo classification of surgical complications

Clavien-Dindo classification of postoperative device related adverse events and serious device related adverse events.

Time frame
within 90 days, +/- 14 days
4

Readmission to hospital

Readmission to hospital for study index procedure-related complications

Time frame
within 30 and 90 day, +/- 14 days

Sponsors and contacts

Click on the lead sponsor to view all of their trials.